>>Signaling Pathways>> Others>>(2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG)

(2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) (Synonyms: (2R)Octyl2-HG)

Catalog No.GC32754

(2R)-옥틸-&알파;-하이드록시글루타레이트((2R)-옥틸-2-HG)((2R)-옥틸-2-HG)는 D-이성체 2-하이드록시글루타레이트의 변형된 형태입니다.

Products are for research use only. Not for human use. We do not sell to patients.

(2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) Chemical Structure

Cas No.: 1391194-67-4

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$129.00
재고 있음
1mg
US$45.00
재고 있음
5mg
US$135.00
재고 있음
10mg
US$216.00
재고 있음
25mg
US$432.00
재고 있음
200mg
US$2,138.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) is a modified form of D-isomer 2-Hydroxyglutarate.

Treatment of IDH1-WT HeLa cells with (2R)-Octyl-α-hydroxyglutarate, a modified form of 2-Hydroxyglutarate with high cellular uptake, results in a dose-dependent increase in DSBs in log-phase cells. It has been used to examine the contribution of D-2-Hydroxyglutarate to the oxidative mitochondrial processes of IDH1-mutated cancer cells[1].

[1]. Sulkowski PL, et al. 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologousrecombination and induces PARP inhibitor sensitivity. Sci Transl Med. 2017 Feb 1;9(375).

리뷰

Review for (2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG)

Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.